Journals / Türk Nöroloji Dergisi / 2019 / Cilt: 25 - Sayı: 1

Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis

Pediatrik Multipl Sklerozda Fingolimod ve İnterferon Beta-1a’nın Karşılaştırılması

Pages
50–51
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

ÜNSAL, M. A. (2022). Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis. Türk Nöroloji Dergisi, Cilt: 25 - Sayı: 1, 50–51. https://ajindex.com/articles/636691

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Boiko A, Vorobeychik G, Paty D, Devonshire V, Sadovnick D; University of British Columbia MS Clinic Neurologists. Early onset multiple sclerosis: a longitudinal study. Neurology 2002;59:1006-1010
  2. Jancic J, Nikolic B, Ivancevic N, et al. Multiple sclerosis in pediatrics: current concepts and treatment options. Neurol Ther 2016;5:131-143
  3. Kappos L, Radue EW, O’Connor P; FREEDOMS Study Group, et al. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med 2010;362:387-401
  4. Chitnis T, Arnold DL, Banwell B; PARADIGMS Study Group, et al. Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis. N Engl J Med 2018;379:1017-1027.